ADRB2信号通路调控肝癌发生及发展的机制研究
[Abstract]:Background and objective primary liver cancer (primary liver cancer) is the fifth most common malignant tumor in the world, with poor prognosis and high mortality. In 2008, about 75 thousands of newly discovered cases and nearly 700 thousand cases died of liver cancer. In 2012, the number of newly discovered cases had increased to more than 780 thousand. (hepatoce). Llular carcinoma, HCC) is the most common type of tissue in primary liver cancer, and the 85%-90%.HCC of all liver cancer originates from liver cells that form the parenchymal cells of the liver. The incidence of the disease is unevenly distributed worldwide. More than 80% of the cases occur in Africa and East Asia. In all HCC cases, 50% come from China. On the contrary, the incidence of HCC in North America and Europe is very low. There are many factors that cause the heterogeneity of HCC distribution, and environmental factors are also one of the most important aspects. Psychosocial factors are a very important environmental factor, and stress is a kind of social psychological factor which is the biggest response to the body's physiological and pathological changes. There is a lot of evidence to support the hypothesis that chronic stress can affect the growth and progression of cancer. Research shows that sympathetic neurotransmitters, such as catecholamines or neuropeptides, can affect both tumor cell growth and tumor angiogenesis. Therefore, the activation of adrenaline system The growth of different types of tumor has a promoting effect and participates in mediating the effect of stress on the progression of tumor. The catecholamines released by the adrenergic system act as a ligand to bind and activate the adrenergic receptors on the surface of the cell. This study is to investigate the effects of the adrenergic receptor on the tumor cells on the tumor cells to regulate the tumor cells. This study is to investigate whether catecholamines can promote the development and development of hepatocellular carcinoma in this model by establishing a classic model of two ethyl nitrosamine (DEN) induced hepatocellular carcinoma. At the same time, we should further detect the expression level of all kinds of adrenergic receptors in liver cancer tissues and cells to determine which receptor activation can mediate the regulation of catecholamines on the growth of hepatocellular carcinoma. It is only possible to clarify whether stress affects the occurrence and development of hepatocellular carcinoma, and can provide a new method for clinical control of the progression of hepatocellular carcinoma and improving the prognosis of patients. The related research has not been reported at home and abroad. Method 1, the model of hepatocarcinoma induced by two ethyl nitrosamines (DEN) in mice was established by giving mice abdominal cavity. Injecting adrenaline or blocking beta 2 adrenergic receptor (ADRB2) to observe the occurrence of hepatocellular carcinoma and the growth of tumor in mice. 2, using the specific inhibitor ICI118551 of ADRB2, and through the proliferation test of CCK8 cells, cloning and forming experiment, flow cytometry to detect the proportion of apoptotic cells, and so on. The effect of ADRB2 signaling pathway on the proliferation and survival of hepatoma cell lines was detected by external detection. 3, the induction of autophagy by ICI118551 was observed by electronic transmission electron microscopy, and the regulation of autophagy by ICI118551 was detected by Western Blot and GFP-LC3 plasmid transfection: 4, the plasmids needed to interfere with the ADRB2 lentivirus were constructed. Package and purify lentivirus. Through ADRB2 interference cell lines further confirm the regulation of autophagy by ADRB2 signaling pathway; 5, construct a model of autophagy induced in vitro, and observe the regulation of autophagy by ADRB2 specific agonist, formoterol (FOR); 6, use Western Blot technology, immunoprecipitation (IP) and other methods to study the ADRB2 signaling pathway. The mechanism of autophagy regulation; 7, the effect of ADRB2 signaling pathway on the proliferation of tumor cells and the effect of P receptor blocker on tumor growth were detected by subcutaneous tumor bearing model in nude mice. 8, autophagy induced by Sola Feeney was used to detect the ADRB2 signaling pathway by Western Blot technique and GFP-LC3 plasmid transfer. Regulation of induction of autophagy, and through the formation of drug resistant clones, CCK8 cell proliferation test and nude mouse subcutaneous tumor bearing model to detect the effect of ADRB2 signaling pathway on the antitumor effect of sorafeni. Results 1, adrenaline can promote the development and progression of DEN induced hepatocellular carcinoma, and this promotion is achieved by activating ADRB2 2, blocking ADRB2 signaling pathway can inhibit the proliferation and survival of liver cancer cell lines in vitro; 3, ADRB2 signaling pathway has a negative regulation of autophagy, and plays a role by activating Akt and regulating the autophagic complex involved in Beclinl; 4, ADRB2 signaling pathway can inhibit the autophagy degradation of HIFIA and thus promote the grape 5, the subcutaneous tumor test in nude mice confirmed that the activation of ADRB2 signaling pathway could promote the growth of subcutaneous tumors. The beta blocker propranolol could inhibit the growth of the tumor to a certain extent; 6, the ADRB2 signaling pathway could inhibit the autophagy induced by Sola Feeney, and could promote Sola Feeney after blocking the ADRB2 signaling pathway. 7, the expression of ADRB2 in liver cancer tissue and expression of HIFIA can predict the prognosis of liver cancer patients well. Conclusion this study is the first evidence that the ADRB2 signaling pathway can be activated in stress conditions for the occurrence and development of liver cancer in the two aspects of different animal models and in vitro cultured hepatoma cell lines. On the one hand, we found that, on the one hand, the activation of the ADRB2 signaling pathway can enhance the tumorigenicity of the liver cancer cells and the ability to proliferate in vitro; on the other hand, the activation of the ADRB2 signaling pathway also affects the drug sensitivity of sorafeni, which makes the body more tolerant to sorafeni. The negative regulation of cytosolic autophagy increases the stability of HIF1A. Our study for the first time reports the relationship between ADRB2 signaling pathway and autophagy and the effect of autophagy on the proliferation of hepatoma cells. This provides a clue and basis for better understanding of the effects of stress on the progression of liver cancer. The bed explores new ways to treat liver cancer, indicating a new direction.
【学位授予单位】:第二军医大学
【学位级别】:博士
【学位授予年份】:2015
【分类号】:R735.7
【相似文献】
相关期刊论文 前10条
1 吴孟超;;肝癌外科治疗的近期进展[J];中国普外基础与临床杂志;2006年02期
2 张志敏;;肝癌会遗传吗?[J];肝博士;2006年03期
3 徐连根;周晶;雷伟;沈志祥;;瘦素及其受体在肝癌组织中的表达及意义[J];胃肠病学和肝病学杂志;2006年05期
4 魏丽珍;李胜棉;张楠;温登瑰;周烨;王士杰;;688例肝癌患者发病特点及诊疗状况分析[J];肝脏;2010年02期
5 ;我国科研人员发现促进肝癌生长和转移的相关基因[J];临床荟萃;2010年10期
6 吴生;;盘点诱发肝癌的7大元凶[J];肝博士;2012年01期
7 邓庆华;一家四例肝癌报道[J];中国厂矿医学;1995年06期
8 王定珠;;觥筹交错 过度疲劳 肝癌乘机而入[J];健康博览;2005年11期
9 笑山,吴蓉蓉;喝咖啡可以减少肝癌发生率[J];健康之路;2005年04期
10 ;远离肝癌 预防在先[J];农民文摘;2006年02期
相关会议论文 前10条
1 俞顺章;穆丽娜;;饮水中藻类毒素与肝癌关系和控制的研究(摘要)[A];全国肿瘤流行病学和肿瘤病因学学术会议论文集[C];2007年
2 杨秉辉;;肝癌预防的新话题-非酒精性脂肪性肝病与肝癌[A];第十二届全国肝癌学术会议论文汇编[C];2009年
3 丁光伟;杨玉秀;徐秋霞;徐存拴;;肝癌多基因表达异常初步研究[A];第五届全国肝脏疾病临床暨中华肝脏病杂志成立十周年学术会议论文汇编[C];2006年
4 吴孟超;;肝癌外科治疗的近期进展[A];第三届全国重型肝病及人工肝血液净化学术年会论文集(上册)[C];2007年
5 刘耕陶;孙华北;方亚南;;肝癌发生的化学预防[A];第十次中国生物物理学术大会论文摘要集[C];2006年
6 阮秀花;田葱;张效本;张喜梅;;肝癌患者乙型肝炎病毒感染血清流行病学分析[A];第五届全国肝脏疾病临床暨中华肝脏病杂志成立十周年学术会议论文汇编[C];2006年
7 阮秀花;田葱;张效本;张喜梅;;肝癌患者乙型肝炎病毒感染血清流行病学分析[A];第五届全国肝脏疾病临床暨中华肝脏病杂志成立十周年学术会议论文汇编[C];2006年
8 吕岩;韩学锋;;肝癌患者需求的评估[A];中华医学会医学工程学分会第八次学术年会暨《医疗设备信息》创刊20周年庆祝会论文集[C];2006年
9 孙华;魏怀玲;刘耕陶;;双环醇对化学毒物促发肝癌的防治作用及作用机制研究[A];2009医学前沿论坛暨第十一届全国肿瘤药理与化疗学术会议论文集[C];2009年
10 谢静媛;戴炜;涂爱民;赵文高;符花;胡应龙;;深圳地区53例肝癌发生的相关因素探讨[A];全国第2届中西医结合传染病学术会议暨国家中医药管理局第1届传染病协作组会议论文汇编[C];2008年
相关重要报纸文章 前10条
1 湖北宜昌 胡献国;吸烟与肝癌[N];上海中医药报;2013年
2 四川成都 孙清廉;远离肝癌 谨防四大危险因素[N];上海中医药报;2013年
3 特约撰稿 北京朝阳医院京西院区肝胆外科主任 孙文兵;警惕肝癌的过度治疗[N];医药导报;2007年
4 健康时报特约记者 孙理;三招不得肝癌[N];健康时报;2008年
5 叶建平;专家提醒肝癌患者保护生命 重在“三早”防治[N];中国中医药报;2008年
6 通讯员 韦夏 本报记者 邓宏鹰 钟少鸿;不良饮食习惯易诱发肝癌[N];中国食品报;2009年
7 记者 顾泳;我国肝癌患者占全球55%[N];解放日报;2010年
8 解放军302医院 刘士敬;四成肝癌酒精泡出来的[N];健康时报;2010年
9 记者 颜维琦 曹继军;我科学家揭示肝癌发生早期分子机制[N];光明日报;2012年
10 记者 胡德荣;肝癌发生早期阶段分子机制被揭示[N];健康报;2012年
相关博士学位论文 前10条
1 陈放;TOPK蛋白和肝癌发生以及相关调控机制的研究[D];复旦大学;2011年
2 张怡安;中枢神经特异性RNA结合蛋白NOVA1在肝癌中的表达及其促进肿瘤发展的潜在分子机制探究[D];复旦大学;2014年
3 殷杰;E3泛素连接酶Prp19对肝癌侵袭的影响及其机制研究[D];复旦大学;2014年
4 周宇红;分化抑制因子ID1在调控化疗诱导的肝癌细胞“干性”改变中的作用研究[D];复旦大学;2014年
5 王盛;FOXA1基因变异和调控异常促,
本文编号:2154548
本文链接:https://www.wllwen.com/yixuelunwen/zlx/2154548.html